JP Patent

JP6882256B2 — 骨格異形成症を処置するためのｃ型ナトリウム利尿ペプチド変異体の使用

Assigned to Biomarin Pharmaceutical Inc · Expires 2021-06-02 · 5y expired

What this patent protects

Patent listed against vosoritide.

Drugs covered by this patent

vosoritide (VOSORITIDE)

Patent Metadata

Patent number: JP6882256B2
Jurisdiction: JP
Classification: —
Expires: 2021-06-02
Drug substance claim: No
Drug product claim: No
Assignee: Biomarin Pharmaceutical Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.